INS and Hyperinsulinemia: In conclusion, daily insulin glargine administration (4 U/kg) develops a progressive insulin action impairment time-dependent model, observing significant changes in signaling, glucose and metabolic lipids, redox balance, and zoometry associated with hyperinsulinemia, reduced hepatic insulin sensitivity, peripheral IR, and early hepatic IR.